Kobayashi Pharmaceutical Co Ltd
TSE:4967

Watchlist Manager
Kobayashi Pharmaceutical Co Ltd Logo
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Watchlist
Price: 5 802 JPY -0.89% Market Closed
Market Cap: ¥431.3B

EV/IC

1.9
Current
4%
Cheaper
vs 3-y average of 2

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
1.9
=
Enterprise Value
¥370.2B
/
Invested Capital
¥189.8B

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
1.9
=
Enterprise Value
¥370.2B
/
Invested Capital
¥189.8B

Valuation Scenarios

Kobayashi Pharmaceutical Co Ltd is trading below its 3-year average

If EV/IC returns to its 3-Year Average (2), the stock would be worth ¥6 023.15 (4% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-50%
Maximum Upside
+42%
Average Downside
13%
Scenario EV/IC Value Implied Price Upside/Downside
Current Multiple 1.9 ¥5 802
0%
3-Year Average 2 ¥6 023.15
+4%
5-Year Average 2.7 ¥8 226.71
+42%
Industry Average 1 ¥2 901.34
-50%
Country Average 1 ¥2 931.18
-49%

Forward EV/IC
Today’s price vs future invested capital

Not enough data available to calculate forward EV/IC

Peer Comparison

All Multiples
EV/IC
P/E
All Countries
Close
Market Cap EV/IC P/E
JP
Kobayashi Pharmaceutical Co Ltd
TSE:4967
431.3B JPY 1.9 118
FR
L'Oreal SA
PAR:OR
195.4B EUR 4.3 31.9
UK
Unilever PLC
LSE:ULVR
93.7B GBP 2.6 11.4
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.4T INR 8.7 36.4
UK
HALEON PLC
LSE:HLN
30.3B GBP 1.3 18.2
US
Estee Lauder Companies Inc
NYSE:EL
27.7B USD 2.1 -155.9
DE
Beiersdorf AG
XETRA:BEI
15.5B EUR 1.7 16.5
JP
Kao Corp
TSE:4452
2.7T JPY 1.9 22
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.1T INR 7.4 59.9
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD 13 371.8 -4 624.4
IN
Dabur India Ltd
NSE:DABUR
808.8B INR 7.8 42.6
P/E Multiple
Earnings Growth PEG
JP
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Average P/E: 39.6
118
72%
1.6
FR
L'Oreal SA
PAR:OR
31.9
13%
2.5
UK
Unilever PLC
LSE:ULVR
11.4
-6%
N/A
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
36.4
7%
5.2
UK
HALEON PLC
LSE:HLN
18.2
11%
1.7
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -155.9 N/A N/A
DE
Beiersdorf AG
XETRA:BEI
16.5
6%
2.7
JP
Kao Corp
TSE:4452
22
10%
2.2
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
59.9
18%
3.3
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -4 624.4 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
42.6
11%
3.9

Market Distribution

Higher than 76% of companies in Japan
Percentile
76th
Based on 5 142 companies
76th percentile
1.9
Low
0 — 0.7
Typical Range
0.7 — 1.5
High
1.5 —
Distribution Statistics
Japan
Min 0
30th Percentile 0.7
Median 1
70th Percentile 1.5
Max 23 050 349

Kobayashi Pharmaceutical Co Ltd
Glance View

Market Cap
431.3B JPY
Industry
Consumer products

In the bustling landscape of Japanese business, Kobayashi Pharmaceutical Co., Ltd. stands as an epitome of innovation and tradition. Founded in 1886, this company, steeped in history, has consistently demonstrated a knack for transforming simple consumer needs into thriving business opportunities. Core to its operations is the development, manufacturing, and marketing of consumer healthcare products that subtly blend pharmaceutical expertise with daily convenience. This approach has allowed Kobayashi Pharmaceutical to carve out a distinctive niche, particularly in over-the-counter (OTC) health and personal care products. The company's vast array of products is remarkably diverse, ranging from cooling gel sheets for fevers to herbal medicinal drinks, each crafted with an understanding of consumer pain points and a commitment to well-being. What sets Kobayashi apart in the competitive market is its strategic focus on niche products that serve unmet needs. This laser-sharp business model does more than just bolster its domestic market; it drives its global expansion into key markets in Asia, North America, and Europe. The company's profitability hinges not just on innovation but also on its agile response to the shifting preferences of health-conscious consumers. Driven by a mission to deliver "small but valuable products," Kobayashi’s nimble approach, coupled with an impressive R&D focus, ensures that it remains at the forefront of both consumer satisfaction and shareholder value. Much like a well-crafted Japanese garden, every part of Kobayashi's operation is meticulously designed to function harmoniously, making it a standout player in the global consumer healthcare industry.

Intrinsic Value
5 270.32 JPY
Overvaluation 9%
Intrinsic Value
Price ¥5 802
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett